TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive NCAB Settles PDQ Controversy; More CCOP Awards May Be Made, Center Guidelines Revisions Coming October 7, 1983
TCL Archive Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development. March 10, 2000